Delivery Order SPE2DB20D2002-SPE2DB22FL54M
- Not listed
- This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens to the Defense Logistics Agency (DLA). The $1,462.71 fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,184.05, is a firm fixed price delivery order for Lantus Solostar 100 unit/mL 3mL, a specialty medication. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- This contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL medical supplies to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,187.60 contract has a completion date of June 12, 2023 and was awarded on June 9, 2023. This is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award is for the delivery of Lantus SoloStar 100 unit/ml 3ml insulin products to the U.S. Defense Logistics Agency (DLA). The $2,735.86 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.60 firm-fixed-price delivery order is for the supply of Lantus SoloStar 100 Unit/mL 3mL medication. The award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). The $5,597.75 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,179.87 for the pharmaceutical product Lantus Solostar 100 unit/ml 3ml. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 16, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distributor, holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.60 firm fixed price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used to treat diabetes. The contract has an ultimate completion date of March 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Lantus 100 Unit/mL vials to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a ceiling value of $1,187.40 and a period of performance through March 11, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $1,975.76 for the supply of Lantus Solostar 100 unit/mL 3mL. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 14, 2023. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL54MDelivery Order
This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL injection to the Defense Logistics Agency (DLA). The $1,792.97 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award references critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. In addition, AmerisourceBergen holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/18/22 |